BioNTech Sets Cancer-Drug Deal With Bristol Myers Squibb
Latest News
- IRH to buy Tremont’s majority interest in Alphamin Resources
- AI’s Potential Marketing Payoffs Come With Outsize Brand Risks
- Circle Prices IPO Above Range. The Stock Looks Set to Jump When It Starts Trading Today.
- Ciena Stock Is Falling After Earnings Miss. What We Know.
- Analyst Says NVIDIA (NVDA) is ‘Firing on All Cylinders’ – ‘Everybody Wants Their Product’
- Daily Spotlight: Argus Adjusts S&P 500 EPS Estimates